MedAlliance inscribe al primer paciente estadounidense en su tercer estudio IDE de la FDA: SFA SELUTION4SFA

Posted on by

GINEBRA, 5 de mayo de 2023 /PRNewswire/ — El Dr. Arthur Lee, del Cardiac & Vascular Institute de Florida, ha inscrito al primer paciente estadounidense en el estudio SELUTION4SFA Sirolimus DEB. Este estudio evalúa SELUTION SLR ™ en el tratamiento de la enfermedad oclusiva de la arteria…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.